Market Research Logo

Global Markets for Vaccine Technologies

Global Markets for Vaccine Technologies

Report Scope:

The report intends to explain the critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors, and provides insights to the stakeholders and potential entrants. This report is designed to be a critical decision-making tool for the intended audience, which includes vaccine market players, potential entrants and other professionals involved with, or interested in, immunology and vaccine-preventable diseases. This study contributes to the areas of market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings as well as pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.

The report provides useful information to all the market players, potential entrants, government agencies and other interested parties. As the report also covers various geographic regions in detail, companies interested in expanding their geographic reach will also find this study useful.

Report Includes:

- 92 tables
- An overview of the global market for vaccine technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- A review of vaccine technology and its challenges, innovations, opportunities, and regulatory hurdles
- Evaluations of market sizes and developments for vaccine classes (prophylactic and therapeutic), vaccine types (inactivated, conjugate, attenuated, recombinant vector, subunit, toxoid, combination, and dendritic cells), vaccine end users (humans and animals) and disease indications (infectious, cancer, and allergy)
- Examination of the industry environment, strategies, market influences, and driving forces
- Identification of regional market sizes, prices, and trends
- Analysis of relevant patents
- Company profiles of major key players in the market, including Abbott Laboratories., Baxter International Inc., Bayer Animal Health, GE Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Lg Life Sciences., Novartis Pharma Ag and Thermo Fisher Scientific


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Definitions
Immune System and Vaccines
How Vaccines Work
Types of Immunity
Advantages of Vaccination
History of Vaccines
Types of Vaccines
Adjuvants and Excipients
Infectious Diseases Preventable by Vaccines
Rapid Manufacturing for Pandemics
Laws and Regulations
Opportunities
Current Situation
Chapter 4 Market Breakdown by Human Vaccine
Types of Human Vaccines
Attenuated (Live) Vaccines
Inactivated Vaccines
Conjugate Vaccines
rDNA/DNA Vaccines
Subunit Vaccines
Toxoid Vaccines
Other/Combination Vaccines
Vaccine by Age Group
Vaccine by Disease Type
Chapter 5 Market Breakdown by Animal Vaccines
Animal Vaccines
Market by Type
Chapter 6 Patent Analysis
Patents by Year
Patents by Vaccine Type
Patents by Patent Office
Patents by Company
Patents by Assignee
Chapter 7 Market Breakdown by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of APAC
Rest of World
Chapter 8 Company Profiles
ABBOTT LABORATORIES
AERAS GLOBAL
ASTELLAS PHARMA INC.
ASTRAZENECA PLC
BAXTER INTERNATIONAL INC.
BAYER ANIMAL HEALTH
BHARAT BIOTECH INTERNATIONAL LTD.
BIOLOGICAL E. LTD.
BIO-MANGUINHOS
BIOPROPERTIES PTY LTD.
BOEHRINGER INGELHEIM GMBH
BUL BIO-NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES LTD. (BB-NCIPD LTD.)
CADILA HEALTHCARE LTD. (ZYDUS CADILA)
CEVA SANTE ANIMALE
CHINA NATIONAL BIOTEC GROUP (CNBG)
COLORADO SERUM CO.
CSL LTD.
ELANCO ANIMAL HEALTH
EMERGENT BIOSOLUTIONS INC.
FATRO SPA
GE HEALTHCARE
GENEONE LIFE SCIENCES INC
GENVEC INC.
GEOVAX
GLAXOSMITHKLINE PLC
GREEN CROSS CORP.
IBIO INC.
INSTITUT PASTEUR DE DAKAR
JAPAN BCG LABORATORY
JOHNSON & JOHNSON INC.
LG LIFE SCIENCES
MAXCYTE INC.
MERCK & CO. INC.
MERIAL SAS
NOVARTIS PHARMA AG
PANACEA BIOTEC LTD.
PFENEX INC.
PFIZER INC.
PROFECTUS BIOSCIENCES INC.
PT BIO FARMA
REPLIKINS LTD.
SANOFI PASTEUR
SERUM INSTITUTE OF INDIA LTD.
STATENS SERUM INSTITUT
THERMO FISHER SCIENTIFIC
VALNEVA SE
VIRBAC
XEME BIOPHARMA INC.
ZOETIS INC.
Chapter 9 Appendix
List of Tables
Summary Table : Global Market for Vaccine Technologies, by Segment, Through 2022
Table 1 : History of Vaccines
Table 2 : Types of Attenuated (Live) Vaccines
Table 3 : Advantages and Disadvantages of Attenuated (Live) Vaccines
Table 4 : Types of Inactivated (Killed) Vaccines
Table 5 : Advantages and Disadvantages of Inactivated (Killed) Vaccines
Table 6 : Types of Toxoid Vaccines
Table 7 : Advantages and Disadvantages of Toxoid Vaccines
Table 8 : Types of Subunit Vaccines
Table 9 : Advantages and Disadvantages of Subunit Vaccines
Table 10 : Types of Conjugate Vaccines
Table 11 : Advantages and Disadvantages of Conjugate Vaccines
Table 12 : Types of Recombinant Vector Vaccines
Table 13 : Advantages and Disadvantages of Recombinant Vector Vaccines
Table 14 : Types of DNA Vaccines
Table 15 : Advantages and Disadvantages of DNA Vaccines
Table 16 : Advantages and Disadvantages of RNA Vaccines
Table 17 : Vaccine Excipient and Media Summary, Excipients included in U.S. Vaccines
Table 18 : Vaccine-Preventable Human Viral Diseases
Table 19 : Vaccine-Preventable Human Bacterial Diseases
Table 20 : Vaccine-Preventable Parasitic Animal Diseases Found in Food-Producing Animals
Table 21 : Vaccine-Preventable Bacterial Animal Diseases Found in Food-producing Animals
Table 22 : Vaccine-Preventable Viral Animal Diseases Found in Food-producing Animals
Table 23 : Vaccine-Preventable Parasitic Animal Diseases Found in Companion Animals
Table 24 : Vaccine-Preventable Bacterial Animal Diseases Found in Companion Animals
Table 25 : Vaccine-Preventable Viral Animal Diseases Found in Companion Animals
Table 26 : Vaccine-Preventable Viral Animal Diseases Found in Other Animals
Table 27 : Animal Vaccines for Food-Producing, Companion and Other Animals
Table 28 : Cases of Diphtheria, 2011-2015
Table 29 : WHO Prequalified Vaccines, January 2014-November 2017
Table 30 : Newly Approved Vaccines, January 2014-November 2017
Table 31 : Global Vaccine Recalls, January 2014-November 2017
Table 32 : Global Vaccine Shortage, January 2012-November 2017
Table 33 : Human Vaccines in Research Pipeline, as of November 2017
Table 34 : Alliances and Joint Ventures for the Development of Human and Animal Vaccines, January 2014-November 2017
Table 35 : Recent Vaccine Product launches, January 2014-November 2017
Table 36 : Global Market for Human Vaccines, by Type, Through 2022
Table 37 : Global Market for Attenuated (Live) Vaccine, by Region, Through 2022
Table 38 : Global Market for Inactivated (Killed) Vaccines, by Region, Through 2022
Table 39 : Global Market for Conjugate Vaccines, by Region, Through 2022
Table 40 : Global Market for Recombinant/rDNA/DNA Vaccines, by Region, Through 2022
Table 41 : Global Market for Subunit Vaccines, by Region, Through 2022
Table 42 : Global Market for Toxoid Vaccines, by Region, Through 2022
Table 43 : Global Market for Other/Combination Vaccines, by Region, Through 2022
Table 44 : Global Market for Human Vaccines, by Age Group, Through 2022
Table 45 : Pediatric Vaccines Doses
Table 46 : Pediatric/VFC Vaccine Price List, 2017
Table 47 : Pediatric Influenza Vaccine Price List
Table 48 : Vaccines Dose by Age
Table 49 : Global Market for Human Vaccines for Pediatrics, by Region, Through 2022
Table 50 : Global Market for Human Vaccines for Adults, by Region, Through 2022
Table 51 : Adult Vaccine Price List
Table 52 : Vaccine Price List for Geriatric Population
Table 53 : Global Market for Human Vaccines for Geriatrics, by Region, Through 2022
Table 54 : Vaccines, by Disease Type
Table 55 : Seasonal Influenza Vaccines
Table 56 : Site by Age for Intramuscular Immunization
Table 57 : Nasal Vaccines
Table 58 : Vaccines by Route of Delivery
Table 59 : Global Market for Human Vaccines, by Disease Type, Through 2022
Table 60 : Global Market for Meningococcal/Pneumococcal Vaccines, by Region, Through 2022
Table 61 : Global Market for Influenza Vaccines, by Region, Through 2022
Table 62 : Global Market for Pediatric Polio/Pertussis/Hib Vaccines, by Region, Through 2022
Table 63 : Global Market for Endemic Diseases Vaccines, by Region, Through 2022
Table 64 : Global Market for HPV Vaccines, by Region, Through 2022
Table 65 : Global Market for Rotavirus Vaccines, by Region, Through 2022
Table 66 : Global Market for Vaccines for Other Diseases, by Region, Through 2022
Table 67 : Global Market for Animal Vaccines, by Type, Through 2022
Table 68 : Global Market for Vaccines for Food-Producing Animals, by Region, Through 2022
Table 69 : Global Market for Vaccines for Companion Animals, by Region, Through 2022
Table 70 : Global Market for other Animal Vaccines, by Region, Through 2022
Table 71 : U.S. Patents Issued for Vaccines, by Year, January 2015-November 2017
Table 72 : U.S. Patents by Type of Vaccine, January 2015-November 2017
Table 73 : Patents by Vaccine Type, January 2014-September 2016
Table 74 : Patents by Company, January 2015-November 2017
Table 75 : U.S. Patents by Assignee Type, January 2015-November 2017
Table 76 : UNICEF Vaccination Price and Major Suppliers, 2017
Table 77 : Estimated Life Saved due to Vaccination, 2011-2020 (Assuming No Vaccination as the Counterfactual)
Table 78 : U.S. Recommended Immunization Schedule, by Vaccine Type, 2017
Table 79 : Vaccine Price List, 2017
Table 80 : Immunization Schedule of Germany, 2016
Table 81 : Immunization Schedule of Germany, 2016
Table 82 : Immunization Schedule of France, 2016
Table 83 : Vaccination and Immunization Schedule of China, 2016
Table 84 : Immunization Schedule of Italy, 2016
Table 85 : Immunization Schedule of China, 2016
Table 86 : Immunization Schedule of Japan, 2016
Table 87 : Immunization Schedule of India, 2016
Table 88 : Number of Reported Cases in India, 2013-2016
Table 89 : GAVI Support to India, 2001-2021
Table 90 : Africa WHO/ UNICEF Vaccination Coverage Estimate, 2005-2016
Table 91 : Middle East WHO/ UNICEF Vaccination Coverage Estimate, 2005-2016
Table 92 : Patents Taken into Consideration for this Report
List of Figures
Summary Figure : Global Market for Vaccine Technologies, by Segment, 2016-2022
Figure 1 : Population Percent that can Read and Write Above the Age of 15, 2015
Figure 2 : Infants Lacking Immunization Measles, 2014
Figure 3 : Polio Cases in the U.S., 1950-2015
Figure 4 : Percent of Children Aged 19-35 Months Receiving Vaccinations in the U.S., 2015
Figure 5 : Immunization Coverage Globally, 2016
Figure 6 : Seasonal Flu Vaccination Coverage in the U.S., 2013-2017
Figure 7 : Immunization Globally, 2013-2016
Figure 8 : Diphtheria Cases in the U.S., 1945-2015
Figure 9 : Seasonal Flu Vaccination Coverage in the U.S., 2013-2017
Figure 10 : WHO/UNICEF Vaccine Coverage Estimate, 2015-2016
Figure 11 : Hepatitis A Cases in the U.S., 1990-2014
Figure 12 : Measles Cases in the U.S., 1960-2014
Figure 13 : Chickenpox Cases in the U.S., 1975-2014
Figure 14 : U.S. Patents Issued for Vaccines, by Year, January 2015-November 2017
Figure 15 : U.S. Patents, by Type of Vaccine, January 2015-November 2017
Figure 16 : Global Immunization Coverage, 2016
Figure 17 : Donor Contributions to GAVI Alliance, 2000-2020
Figure 18 : Global Investment in R&D Vaccination, 2012-2015
Figure 19 : Donation from the U.S. to GAVI, 2013-2016
Figure 20 : Canada Cash Funding to GAVI, 2013-2016
Figure 21 : Germany Funding to GAVI, 2013-2016
Figure 22 : France Funding to GAVI, 2012-2015
Figure 23 : U.K. Funding to GAVI, 2013-2016
Figure 24 : Donation of European Governments and Organizations to Gavi, 2013-2016
Figure 25 : Investment by APAC Counties in Vaccination R&D, 2012-2015
Figure 26 : China Support to GAVI, 2001-2021
Figure 27 : Japan Funding to Gavi, 2011-2020
Figure 28 : Australia Funding to GAVI, 2013-2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report